Effects of BBT Versus Diaphragmatic Breathing on Exercise Capacity and Quality of Life in Patients With COPD
1 other identifier
interventional
48
1 country
1
Brief Summary
Group A will be treated with manual chest physical therapy and Buteyko breathing technique Group-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique. Patients will perform the technique 5 times a weeks for 8weeks and treatment evaluation will be done after 8 weeks
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2023
CompletedStudy Start
First participant enrolled
June 15, 2023
CompletedFirst Posted
Study publicly available on registry
July 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2023
CompletedJune 13, 2024
June 1, 2024
2 months
June 14, 2023
June 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6 Minute Walk Distance
Distance will be measured in meter through 6 minute walk test.
4 weeks.
Secondary Outcomes (1)
St George Respiratory Questionnaire for quality of life :
4 weeks.
Other Outcomes (2)
oxygen saturation
4 weeks
heart rate
4 weeks
Study Arms (2)
manual chest physical therapy and Buteyko breathing technique
EXPERIMENTALGroup A will be treated with manual chest physical therapy and Buteyko breathing technique
manual chest physical therapy and Diaphragmatic breathing technique.
EXPERIMENTALGroup-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique.
Interventions
Group A : will be treated with manual chest physiotherapy \& Buteyko Breathing exercise
Group B : will be treated with manual chest physiotherapy \& Diaphragmatic Breathing Treatment evaluation will be done after 8 weeks through 6MWT \& St George respiratory Questionnaire. Patients will perform technique 5 times a weeks for 8 weeks
Eligibility Criteria
You may qualify if:
- Age group : 40-65 years
- Both males and females
- Clinical diagnosis of COPD confirmed by smoking history and PFT airflow
- Patients taking their regular medications e.g bronchodilator
You may not qualify if:
- Restrictive lung disease
- Pneumothorax
- Resting O2 saturation \<90% with room air breathing
- Recent exacerbations
- Patients with active viral or bacterial infection
- Abdominal or thoracic surgery (\<3months ago)
- Cardiologic conditions (\<6months ago e.g Myocardial infarction or unstable angina
- Intubated Patients
- Orthopedic or urogenital conditions
- Neurological disorders limiting cognition \& mobility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulab Devi Hospital, Lahore
Lahore, Punjab Province, Pakistan
Related Publications (7)
Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review. Int J Chron Obstruct Pulmon Dis. 2020 Feb 26;15:439-460. doi: 10.2147/COPD.S234942. eCollection 2020.
PMID: 32161455BACKGROUNDChatreewatanakul B, Othaganont P, Hickman RL. Early symptom recognition and symptom management among exacerbation COPD patients: A qualitative study. Appl Nurs Res. 2022 Feb;63:151522. doi: 10.1016/j.apnr.2021.151522. Epub 2021 Nov 6.
PMID: 35034709BACKGROUNDAdeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I; NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022 May;10(5):447-458. doi: 10.1016/S2213-2600(21)00511-7. Epub 2022 Mar 10.
PMID: 35279265BACKGROUNDGea J, Agusti A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985). 2013 May;114(9):1222-34. doi: 10.1152/japplphysiol.00981.2012. Epub 2013 Mar 21.
PMID: 23519228BACKGROUNDCavalcanti JD, Fregonezi GAF, Sarmento AJ, Bezerra T, Gualdi LP, Pennati F, Aliverti A, Resqueti VR. Electrical activity and fatigue of respiratory and locomotor muscles in obstructive respiratory diseases during field walking test. PLoS One. 2022 Apr 1;17(4):e0266365. doi: 10.1371/journal.pone.0266365. eCollection 2022.
PMID: 35363800BACKGROUNDTang CY, Taylor NF, Blackstock FC. Chest physiotherapy for patients admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease (COPD): a systematic review. Physiotherapy. 2010 Mar;96(1):1-13. doi: 10.1016/j.physio.2009.06.008. Epub 2009 Sep 22.
PMID: 20113757BACKGROUNDVogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, Lopez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
PMID: 28128970BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sidra Faisal, MS.CPPT
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2023
First Posted
July 17, 2023
Study Start
June 15, 2023
Primary Completion
August 15, 2023
Study Completion
November 20, 2023
Last Updated
June 13, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share